Faeth Therapeutics and The Gog Foundation, Inc. Unveil Phase 2 Combination Trial of Sapanisertib and Serabelisib for Endometrial Cancer Patients
In a groundbreaking development in cancer treatment, Faeth Therapeutics, a clinical-stage biotechnology firm, in partnership with The GOG Foundation, Inc, ...
